MariMed Inc (MRMD) Q4 2025 Earnings: What Investors Should Anticipate
“MariMed Inc. (MRMD), a multi-state cannabis operator focused on branded consumer packaged goods and retail, is scheduled to report its fourth quarter and full-year 2025 results imminently. Wall Street consensus points to revenue around $40.6 million to $40.8 million for the quarter, with a per-share loss of $0.01. Full-year figures are projected at approximately $161 … Read more